Objective: was to study success rate, induction abortion interval, mean dose of misoprostol required and complications of medical method of abortion using mifepristone and vaginal misoprostol combination in women with amenorrhea of more than 63 days up to 98 days Methods: Study Design: Prospective Observational study Study period: October 2019 – September 2021 Results: Total 80 women met inclusion criteria and included in the study. The MMAwas successful in 76 (95%) study women. Remaining 4 (5%) women required MVA(Manual vacuum Aspiration). Average duration of bleeding was 3.60 hours ± 2.07 with the range of 1-8 hours. Mean Induction abortion interval was 5.70 hours (SD±2.92) with minimum and maximum interval being 2 hours and 13 hours respectively. Mean dose of misoprostol required was 795ugm with range between 400-2000ugm. Minor side effects such as nausea, vomiting, headache and fever were noted in 7.5% women. No any other complications were seen. Conclusion: Present study demonstrated that use of MMA in the women between gestational age of more than 63 to up to 98 days was safe and effective with lesser side effects.

Dr. Sonali S. Deshpande, Dr. Shrinivas Gadappa, Dr. Mayure Sahebrao Kamble. Study of medical method of abortion (MMA) by mifepristone and vaginal misoprostol in women with amenorrhea of more than 63 days up to 98 days of gestation in a tertiary care hospital. International Journal of Scientific Research; Volume-12; issue-04 April 2023